Breaking News

ResearchDx Completes Relocation

By Gil Roth | July 22, 2013

Celebrates move with open house event

ResearchDx has completed the purchase, build-out and relocation of its 30,000-sq.-ft. facility in Irvine, CA. The custom-designed facility will support the company's expansion of in vitro diagnostic (IVD) development services to the pharma, biotechnology, diagnostic development and clinical laboratory industries.

To celebrate this event, ResearchDx will be holding an open house on Tuesday, July 23 from 1-7 p.m. The event is open to anyone with a professional or personal interest in diagnostics and diagnostic development. Laboratory tours and technology presentations will be conducted throughout the afternoon, and food and beverages will be served. For more information regarding this event please contact Natalie McCan at nmccan@researchdx.com.

ResearchDx provides integrated, flexible services for the IVD development process, including initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, as well clinical research services and regulatory approval.
blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Heavy Metals in Drug Products

    Heavy Metals in Drug Products

    Nikki Schopp, Team Leader in charge of ICP-MS, ICP-OES and AA testing, SGS||January 29, 2015
    The potential presence of trace amounts of heavy metals in drug products is a real cause for concern with regulators.

  • Microbiological Testing & Contamination Control

    Microbiological Testing & Contamination Control

    Daniel L. Prince, Ph. D., Christopher J. Waskewich, M.S., Kristah J. Kohan, B.S. and Danina G. Rinaldi, B.S. , Gibraltar Laboratories, Inc.||March 7, 2014
    An opinion on the microbial limit test with reference to harmonization.